Business
AREV Receives 45 Day Extension to File Quarterly Financial Statements and MD&A
AREV Receives 45 Day Extension to File Quarterly Financial Statements and MD&A.
About this update from Arev Life Sciences Global Corp.
[{"type":"text","content":"VANCOUVER, BC / April 28, 2020 / AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVD) (“AREV Brands”) announces the Company has provided an update on the status of the filing of its:annual audited financials statements, the accompanying management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the filings ended December 31, 2019; andquarterly financial statements, the accompanying management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the filings first quarter ended March 31, 2020 .On March 18, 2020, the Canadian Securities Administrators (CSA) announced that they will provide issuers with a 45-day filing extension for filings required on or before June 1, 2020 to allow issuers the time needed to focus on the many other business and financial reporting implications of COVID-19. The Company will rely on this exemption with respect to the quarterly filings in accordance with BC Instrument 51-515, Temporary Exemption from Certain Corporate Finance Requirements.Members of the Company's management and other insiders are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207. The Company expects to file the Documents on or before the end of the available 45 extension period. An update on material business developments since the filing of the Company's interim financial reports has been provided in prior press releases.For further information, contact Mike Withrow, [email protected] 778-929-6536.On behalf of the Board,Mike WithrowCEO & DirectorAbout AREV NanoTec Inc. AREV NanoTec Brands Inc. (“AREV”) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREV’s model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada. The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT R...